• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血、肝酶升高和血小板计数降低综合征患者体内过敏毒素和终末C5b-9补体复合物形成增强。

Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

作者信息

Haeger M, Unander M, Bengtsson A

机构信息

Department of Obstetrics and Gynecology, Sahlgren Hospital, Göteborg, Sweden.

出版信息

Obstet Gynecol. 1990 Oct;76(4):698-702.

PMID:2216207
Abstract

Complement activation was studied in ten consecutive pregnant women developing hemolysis, elevated liver enzymes, and low platelet count (HELLP syndrome) and ten other women with normal pregnancies. Blood samples for anaphylatoxin (C3a/C3a desArg and C5a/C5a desArg) and terminal C5b-9 complement complex determinations were drawn at delivery and 24 hours and 7 days later. Women developing HELLP syndrome had higher plasma levels of anaphylatoxins with delivery than did women with uneventful pregnancies. The plasma levels of terminal C5b-9 complement complexes at the time of delivery were increased as compared with levels 1 and 7 days after delivery in women with HELLP syndrome. The plasma concentrations of the anaphylatoxins and the terminal C5b-9 complement complexes returned to normal levels within 1 week after delivery in the HELLP group. The formation of C5b-9 complement complex indicates that the terminal part of the complement cascade has been activated and that C5a has been formed and eliminated. Complement activation with release of anaphylatoxins and terminal C5b-9 complement complexes may be one etiologic factor behind the elevated blood pressure, hemolysis, liver insufficiency, and platelet consumption seen in these patients.

摘要

对10例连续发生溶血、肝酶升高和血小板计数降低(HELLP综合征)的孕妇以及10例其他正常妊娠的孕妇进行了补体激活研究。在分娩时、24小时后和7天后采集血样,用于测定过敏毒素(C3a/C3a去精氨酸和C5a/C5a去精氨酸)和末端C5b-9补体复合物。发生HELLP综合征的孕妇分娩时血浆过敏毒素水平高于妊娠过程顺利的孕妇。与HELLP综合征孕妇分娩后1天和7天的水平相比,分娩时末端C5b-9补体复合物的血浆水平升高。在HELLP组中,过敏毒素和末端C5b-9补体复合物的血浆浓度在分娩后1周内恢复到正常水平。C5b-9补体复合物的形成表明补体级联反应的末端部分已被激活,并且C5a已形成并被清除。过敏毒素和末端C5b-9补体复合物的释放所导致的补体激活可能是这些患者出现血压升高、溶血、肝功能不全和血小板消耗的一个病因。

相似文献

1
Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.溶血、肝酶升高和血小板计数降低综合征患者体内过敏毒素和终末C5b-9补体复合物形成增强。
Obstet Gynecol. 1990 Oct;76(4):698-702.
2
Complement activation in relation to development of preeclampsia.与子痫前期发展相关的补体激活
Obstet Gynecol. 1991 Jul;78(1):46-9.
3
Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count.重度子痫前期及溶血、肝酶升高和血小板减少综合征女性患者的补体、中性粒细胞及巨噬细胞激活
Obstet Gynecol. 1992 Jan;79(1):19-26.
4
Human serum complement C3 and factor H in the syndrome of hemolysis, elevated liver enzymes, and low platelet count.人类血清补体C3和因子H与溶血、肝酶升高和血小板计数降低综合征
Am J Reprod Immunol. 2009 Oct;62(4):238-42. doi: 10.1111/j.1600-0897.2009.00731.x. Epub 2009 Aug 24.
5
Preeclampsia/eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia.伴有溶血、肝酶升高和血小板减少的子痫前期/子痫
Obstet Gynecol. 1985 Nov;66(5):657-60.
6
Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.子痫前期及羊水导致的补体激活和过敏毒素(C3a和C5a)形成。
Obstet Gynecol. 1989 Apr;73(4):551-6.
7
Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome.补体激活与调节在子痫前期及溶血性贫血、肝酶升高和血小板计数减少综合征中的作用。
Am J Obstet Gynecol. 2022 Feb;226(2S):S1059-S1070. doi: 10.1016/j.ajog.2020.09.038. Epub 2020 Sep 25.
8
Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.溶血、肝酶升高和血小板计数降低综合征女性患者中肿瘤坏死因子-α和白细胞介素-6释放增加。
Acta Obstet Gynecol Scand. 1996 Sep;75(8):695-701. doi: 10.3109/00016349609065729.
9
Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.人类原位肝移植过程中的补体系统激活。肠道中围手术期补体系统激活的迹象。
Transplantation. 1994 Jun 15;57(11):1594-7.
10
Hemolysis, elevated liver enzymes and low platelet count. The HELLP syndrome.溶血、肝酶升高和血小板计数降低。HELLP综合征。
West J Med. 1986 Jan;144(1):81-3.

引用本文的文献

1
The role of complement in normal pregnancy and preeclampsia.补体在正常妊娠和子痫前期中的作用。
Front Immunol. 2025 Jul 24;16:1643896. doi: 10.3389/fimmu.2025.1643896. eCollection 2025.
2
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study.窦性阻塞综合征/静脉闭塞性疾病的遗传易感性:一项病例对照研究。
Int J Mol Sci. 2025 Jul 12;26(14):6712. doi: 10.3390/ijms26146712.
3
A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
妊娠相关性非典型溶血尿毒综合征/补体介导的血栓性微血管病的病例叙述性综述。
Kidney Int. 2024 May;105(5):960-970. doi: 10.1016/j.kint.2023.12.021. Epub 2024 Feb 24.
4
Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease.窦房阻塞综合征/静脉阻塞性疾病的分子进展。
Int J Mol Sci. 2023 Mar 15;24(6):5620. doi: 10.3390/ijms24065620.
5
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity.内皮损伤综合征的新纪元:嵌合抗原受体 T 细胞的毒性和免疫的作用。
Int J Mol Sci. 2020 May 29;21(11):3886. doi: 10.3390/ijms21113886.
6
Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics.补体在血栓性微血管病中的作用:揭开补体治疗学迷宫中的阿里阿德涅之线。
Front Immunol. 2019 Feb 27;10:337. doi: 10.3389/fimmu.2019.00337. eCollection 2019.
7
Germline mutations in the alternative pathway of complement predispose to HELLP syndrome.胚系补体旁路基因突变可导致 HELLP 综合征。
JCI Insight. 2018 Mar 22;3(6):99128. doi: 10.1172/jci.insight.99128.
8
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.用于血栓性微血管病的补体C5抑制疗法:证据不断积累,但并非万灵药。
Clin Kidney J. 2017 Oct;10(5):600-624. doi: 10.1093/ckj/sfx081. Epub 2017 May 8.
9
Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome.HELLP综合征中补体激活的直接证据:与非典型溶血性尿毒症综合征的联系。
Exp Hematol. 2016 May;44(5):390-8. doi: 10.1016/j.exphem.2016.01.005. Epub 2016 Feb 26.
10
The complement system and adverse pregnancy outcomes.补体系统与不良妊娠结局
Mol Immunol. 2015 Sep;67(1):56-70. doi: 10.1016/j.molimm.2015.02.030. Epub 2015 Mar 21.